Daratumumab plus bortezomib, melphalan, and prednisone in East Asian patients with non-transplant multiple myeloma: subanalysis of the randomized phase 3 ALCYONE trial

In conclusion, D-VMP was safe and efficacious in East Asian patients, consistent with the global ALCYONE population.
Source: Annals of Hematology - Category: Hematology Source Type: research